153 related articles for article (PubMed ID: 22934741)
21. Efficacy of the antioxidant ebselen in experimental uveitis.
Bosch-Morell F; Romá J; Puertas FJ; Marín N; Díaz-Llopis M; Romero FJ
Free Radic Biol Med; 1999 Aug; 27(3-4):388-91. PubMed ID: 10468213
[TBL] [Abstract][Full Text] [Related]
22. Recent developments in the treatment of uveitis: an update.
Lyon F; Gale RP; Lightman S
Expert Opin Investig Drugs; 2009 May; 18(5):609-16. PubMed ID: 19388878
[TBL] [Abstract][Full Text] [Related]
23. Emerging drugs for the treatment of uveitis.
Leung TG; Thorne JE
Expert Opin Emerg Drugs; 2013 Dec; 18(4):513-21. PubMed ID: 24274613
[TBL] [Abstract][Full Text] [Related]
24. [Juvenile idiopathic arthritis and uveitis: screening and anti-inflammatory therapy].
Heiligenhaus A; Mingels A; Neudorf U; Ganser G
Klin Monbl Augenheilkd; 2003 Nov; 220(11):738-53. PubMed ID: 14634901
[TBL] [Abstract][Full Text] [Related]
25. Molecular mimicry as a therapeutic approach for an autoimmune disease: oral treatment of uveitis-patients with an MHC-peptide crossreactive with autoantigen--first results.
Thurau SR; Diedrichs-Möhring M; Fricke H; Arbogast S; Wildner G
Immunol Lett; 1997 Jun; 57(1-3):193-201. PubMed ID: 9232451
[TBL] [Abstract][Full Text] [Related]
26. Immunomodulatory therapy for ocular inflammatory disease: a basic manual and review of the literature.
Okada AA
Ocul Immunol Inflamm; 2005; 13(5):335-51. PubMed ID: 16419419
[TBL] [Abstract][Full Text] [Related]
27. Road to remission: a comprehensive review of therapy in uveitis.
Siddique SS; Shah R; Suelves AM; Foster CS
Expert Opin Investig Drugs; 2011 Nov; 20(11):1497-515. PubMed ID: 21936708
[TBL] [Abstract][Full Text] [Related]
28. [New methods of therapy for ocular inflammatory autoimmune diseases].
Kubicka-Trzaska A; Undas A
Klin Oczna; 2003; 105(6):428-32. PubMed ID: 15049272
[TBL] [Abstract][Full Text] [Related]
29. Peptides as Therapeutic Agents for Inflammatory-Related Diseases.
La Manna S; Di Natale C; Florio D; Marasco D
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30208640
[TBL] [Abstract][Full Text] [Related]
30. Toward new therapies for ocular inflammation.
Rosenbaum JT; Becker MD; Smith JR
Arch Soc Esp Oftalmol; 2000 Aug; 75(8):511-4. PubMed ID: 11151211
[TBL] [Abstract][Full Text] [Related]
31. Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome.
Kiss S; Letko E; Qamruddin S; Baltatzis S; Foster CS
Ophthalmology; 2003 Sep; 110(9):1764-9. PubMed ID: 13129875
[TBL] [Abstract][Full Text] [Related]
32. Approaches to immunosuppression in Behçet's disease.
Comarmond C; Wechsler B; Cacoub P; Saadoun D
Immunotherapy; 2013 Jul; 5(7):743-54. PubMed ID: 23829625
[TBL] [Abstract][Full Text] [Related]
33. Update on medical management of inflammatory bowel disease: ulcerative colitis.
Hanauer SB
Rev Gastroenterol Disord; 2001; 1(4):169-76. PubMed ID: 12120183
[TBL] [Abstract][Full Text] [Related]
34. Immunotherapeutic approaches in ocular inflammatory diseases.
Kurup SK; Chan CC
Arch Immunol Ther Exp (Warsz); 2005; 53(6):484-96. PubMed ID: 16407781
[TBL] [Abstract][Full Text] [Related]
35. [Anti-TNF-α in the treatment of uveitis in the Besançon Hospital].
Fery-Blanco C; Schwartz C; Gil H; Curlier E; Prati C; Delbosc B
J Fr Ophtalmol; 2011 Dec; 34(10):697-702. PubMed ID: 21889230
[TBL] [Abstract][Full Text] [Related]
36. In vivo studies validating multitargeting of prostanoid receptors for achieving superior anti-inflammatory effects.
Woodward DF; Wang JW; Ni M; Bauer A; Martos JL; Carling RW; Poloso NJ
FASEB J; 2017 Jan; 31(1):368-375. PubMed ID: 27770021
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the long-term efficacy and safety of infliximab treatment for uveitis in Behçet's disease: a multicenter study.
Takeuchi M; Kezuka T; Sugita S; Keino H; Namba K; Kaburaki T; Maruyama K; Nakai K; Hijioka K; Shibuya E; Komae K; Hori J; Ohguro N; Sonoda KH; Mizuki N; Okada AA; Ishibashi T; Goto H; Mochizuki M
Ophthalmology; 2014 Oct; 121(10):1877-84. PubMed ID: 24950593
[TBL] [Abstract][Full Text] [Related]
38. Immunomodulatory therapy in ophthalmology - is there a place for topical application?
Bertelmann E; Pleyer U
Ophthalmologica; 2004; 218(6):359-67. PubMed ID: 15564752
[TBL] [Abstract][Full Text] [Related]
39. [Treatment of posterior noninfectious uveitis : Current situation and future developments].
Pleyer U; Pohlmann D; Stübiger N
Ophthalmologe; 2016 May; 113(5):380-90. PubMed ID: 27165275
[TBL] [Abstract][Full Text] [Related]
40. The philosophy of treatment of uveitis: past, present and future.
Kruh J; Foster CS
Dev Ophthalmol; 2012; 51():1-6. PubMed ID: 22517200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
